Differential androgen and estrogen substrates specificity in the mouse and primates type 12 17β-hydroxysteroid dehydrogenase

Journal of Endocrinology

Volumn 194, Issue 2, 2007, Pages 449-455

  Bianchard, Pierre Gilles ^a   Luu The, Van ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANDROGEN; ANDROSTANEDIOL; ANDROSTENEDIOL; ANDROSTENEDIONE; ANDROSTERONE; COMPLEMENTARY DNA; DNA FRAGMENT; ESTRADIOL; ESTROGEN; ESTRONE; LEUCINE; MESSENGER RNA; PHENYLALANINE; PRASTERONE; STEROID HORMONE; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE;

ADRENAL GLAND; AMINO ACID SUBSTITUTION; ANDROGEN METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEK293; CLITORIS; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME SPECIFICITY; FEMALE; GENETIC CODE; GONAD; HUMAN; HUMAN CELL; MALE; MONKEY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREPUTIAL GLAND; PRIMATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN PROCESSING; REAL TIME POLYMERASE CHAIN REACTION; RETROPERITONEAL FAT; RNA ANALYSIS; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS; STEREOSPECIFICITY;

17-HYDROXYSTEROID DEHYDROGENASES; ADRENAL GLANDS; ANDROGENS; ANIMALS; BASE SEQUENCE; CELL LINE; CYTOMEGALOVIRUS; ESTROGENS; FEMALE; GENETIC ENGINEERING; GENETIC VECTORS; HAPLORHINI; HUMANS; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PRIMATES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY; SUBSTRATE SPECIFICITY; TISSUE DISTRIBUTION; TRANSFECTION;

EID: 34547896978     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/JOE-07-0144     Document Type: Article

References (41)

1. Andersson S, Berman DM, Jenkins EP & Russell DW 1991 Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism. Nature 354 159-161.
2. Blouin K, Richard C, Brochu G, Hould FS, Lebel S, Marceau S, Biron S, Luu-The V & Tchernof A 2006 Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men. Journal of Endocrinology 191 637-649.
3. Buzdar A 2000 Exemestane in advanced breast cancer. Anticancer Drugs 11 609-616.
4. Cheng KC, White PC & Qin KN 1991 Molecular cloning and expression of rat liver 3α-hydroxysteroid dehydrogenase. Molecular Endocrinology 5 823-828.
5. Dufort I, Rheault P, Huang X-F, Soucy P & Luu-The V 1999 Characteristics of a highly labile human type 5 17β-hydroxysteroid dehydrogenase. Endocrinology 140 568-574.
6. Dufort I, Labrie F & Luu-The V 2001 Human types 1 and 3 3α-hydroxysteroid dehydrogenases: differential lability and tissue distribution. Journal of Clinical Endocrinology and Metabolism 86 841-846.
7. Ekman P 1999 Finasteride in the treatment of benign prostatic hypertrophy: an update. New indications for finasteride therapy. Scandinavian Journal of Urology and Nephrology 203 15-20.
8. Fruzzetti F, Bersi C, Parrini D, Ricci C & Genazzani AR 1999 Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects. Fertility and Sterility 71 445-451.
9. Ghersevich S, Nokelainen P, Poutanen M, Orava M, Autio-Harmainen H, Rajaniemi H & Vihko R 1994a Rat 17β-hydroxysteroid dehydrogenase type 1: primary structure and regulation of enzyme expression in rat ovary by diethylstilbestrol and gonadotropins in vivo. Endocrinology 135 1477-1487.
10. Ghersevich S, Poutanen M, Tapanainen J & Vihko R 1994b Hormonal regulation of rat 17β-hydroxysteroid dehydrogenase type 1 in cultured rat granulosa cells: effects of recombinant follicle-stimulating hormone, estrogens, androgens, and epidermal growth factor. Endocrinology 135 1963-1971.
11. Gibori G, Khan I, Warshaw NIL, McLean MP, Puryear TK, Nelson S, Durkee TJ, Azhar S, Steinschneider A & Rao MC 1988 Placental-derived regulators and the complex control of luteal cell function. Recent Progress in Hormone Research 44 377-429.
12. Goss PE & Strasser-Weippl K 2004 Prevention strategies with aromatase inhibitors. Clinical Cancer Research 10 372S-379S.
13. Howell A, Robertson JF & Vergote I 2003 A review of the efficacy of anastrozole in postmenopausal women with advanced breast cancer with visceral metastases. Breast Cancer Research and Treatment 82 215-222.
14. Huang XF & Luu-The V 2000 Molecular characterization of a first human 3(α → β)-hydroxysteroid epimerase. Journal of Biological Chemistry 275 29452-29457.
15. Kershaw EE & Flier JS 2004 Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism 89 2548-2556.
16. Labrie F 1991 Intracrinology. Molecular and Cellular Endocrinology 78 C113-C118.
17. Labrie F, Sugimoto Y, Luu-The V, Simard J, Lachance Y, Bachvarov D, Leblanc G, Durocher F & Paquet N 1992 Structure of human type II 5α-reductase gene. Endocrinology 131 1571-1573.
18. 4 isomerase gene and its expression in mammalian cells. Journal of Biological Chemistry 265 20469-20475.
19. 4 isomerase (3β-HSD) gene: adrenal and gonadal specificity. DNA and Cell Biology 10 701-711.
20. Liu H, Robert A & Luu-The V 2005 Cloning and characterization of human form 2 type 7 17β-hydroxysteroid dehydrogenase, a primarily 3β-keto reductase and estrogen activating and androgen inactivating enzyme. Journal of Steroid Biochemistry and Molecular Biology 94 173-179.
21. Liu H, Zheng S, Bellemare V, Pelletier G, Labrie F & Luu-The V 2007 Expression and localization of estrogenic type 12 17β-hydroxysteroid dehydrogenase in the cynomolgus monkey. BMC Biochemistry 8 2.
22. Luu-The V 2001 Analysis and characteristics of multiple types of human 17β-hydroxysteroid dehydrogenases. Journal of Steroid Biochemistry and Molecular Biology 76 143-151.
23. Luu-The V, Labrie C, Zhao HF, Couet J, Lachance Y, Simard J, Leblanc G, Cote J, Berube D, Gagne R et al. 1989 Characterization of cDNAs for human estradiol 17β-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5′-termini in human placenta. Molecular Endocrinology 3 1301-1309.
24. Luu-The V, Pelletier G & Labrie F 2005a Quantitative appreciation of steroidogenic gene expression in mouse tissues: new roles for type 2 5α-reductase, 20α-hydroxysteroid dehydrogenase and estrogen sulfotransferase. Journal of Steroid Biochemistry and Molecular Biology 93 269-276.
25. Luu-The V, Paquet N, Calvo E & Cumps J 2005b Improve real-time RT-PCR method for high throughput measurements using second derivative calculation and double correction. Bio Techniques 32 287-293.
26. Luu-The V, Tremblay P & Labrie F 2006 Characterization of type 12 17β-hydroxysteroid dehydrogenase, an isoform of type 3 17β-hydroxysteroid dehydrogenase responsible for estradiol formation in women. Molecular Endocrinology 20 437-443.
27. Marijanovic Z, Laubner D, Moller G, Gege C, Husen B, Adamski J & Breitling R 2003 Closing the gap: identification of human 3-ketosteroid reductase, the last unknown enzyme of mammalian cholesterol biosynthesis. Molecular Endocrinology 17 1715-1725.
28. Mazza C, Breton R, Housset D & Fontecilla-Camps JC 1998 Unusual charge stabilization of NADP + in 17β-hydroxysteroid dehydrogenase. Journal of Biological Chemistry 273 8145-8152.
29. Mindnich R, Moller G & Adamski J 2004 The role of 17β-hydroxysteroid dehydrogenases. Molecular and Cellular Endocrinology 218 7-20.
30. Moon YA & Horton JD 2003 Identification of two mammalian reductases involved in the two-carbon fatty acyl elongation cascade. Journal of Biological Chemistry 278 7335-7343.
31. Mustonen MV, Poutanen MH, Isomaa VV, Vihko PT & Vihko RK 1997 Cloning of mouse 17β-hydroxysteroid dehydrogenase type 2, and analysing expression of the mRNAs for types 1, 2, 3, 4 and 5 in mouse embryos and adult tissues. Biochemical Journal 325 199-205.
32. Van Neste D, Fuh V, Sanchez-Pedreno P, Lopez-Bran E, Wolff H, Whiting D, Roberts J, Kopera D, Stene JJ, Calvieri S et al. 2000 Finasteride increases anagen hair in men with androgenetic alopecia. British Journal of Dermatology 143 804-810.
33. Nokelainen P, Peltoketo H, Vihko R & Vihko P 1998 Expression cloning of a novel estrogenic mouse 17β-hydroxysteroid dehydrogenase/ 17-ketosteroid reductase (m17HSD7), previously described as a prolactin receptor-associated protein (PRAP) in rat. Molecular Endocrinology 12 1048-1059.
34. Peltoketo, H, Isomaa V, Maentausta O & Vihko R. 1988 Complete amino acid sequence of human placental 17β-hydroxysteroid dehydrogenase deduced from cDNA. FEBS Letters 239 73-77.
35. Peltoketo, H, Luu-The V, Simard J & Adamski J 1999 17β-Hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes. Journal of Molecular Endocrinology 23 1-11.
36. 4-isomerase in human adrenals and gonads. Molecular Endocrinology 5 1147-1157.
37. Rheaume E, Simard J, Morel Y, Mebarki F, Zachmann M, Forest MG, New MI & Labrie F 1992 Congenital adrenal hyperplasia due to point mutations in the type II 3β-hydroxysteroid dehydrogenase gene. Nature Genetics 1 239-245.
38. Sawetawan C, Milewich L, Word RA, Carr BR & Rainey WE 1994 Compartmentalization of type I 17β-hydroxysteroid oxidoreductase in the human ovary. Molecular and Cellular Endocrinology 99 161-168.
39. Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, Amarneh B, Ito Y, Fisher CR, Michael MD et al. 1994 Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocrine Reviews 15 342-355.
40. Simpson ER, Michael MD, Agarwal VR, Hinshelwood MM, Bulun SE & Zhao Y 1997 Cytochromes P450 11: expression ofthe CYP19 (aromatase) gene: an unusual case of alternative promoter usage. FASEB Journal 11 29-36.
41. Torn S, Nokelainen P, Kurkela R, Pulkka A, Menjivar M, Ghosh S, Coca-Prados M, Peltoketo H, Isomaa V & Vihko P 2003 Production, purification, and functional analysis of recombinant human and mouse 17β-hydroxysteroid dehydrogenase type 7. Biochemical and Biophysical Research Communications 305 37-45.